These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2164182)

  • 1. [Mathematical study of the sensitivity curves of Escherichia coli exposed to polymyxins].
    Peyret M; Carret G; Carre C; Fardel G; Flandrois JP
    Pathol Biol (Paris); 1990 May; 38(5):441-5. PubMed ID: 2164182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Time-killing curves of Pseudomonas aeruginosa strains exposed to polymyxin B].
    Peyret M; Flandrois JP; Fardel G
    Pathol Biol (Paris); 1991 May; 39(5):446-50. PubMed ID: 1909018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The susceptibility of enteropathogenic and non-enteropathogenic porcine Escherichia coli strains to polymyxins and other antibiotics.
    Larsen JL; Søgaard H
    Nord Vet Med; 1981; 33(9-11):393-402. PubMed ID: 6276857
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of planktonic and biofilm of Escherichia coli by the synergistic lantibiotics-polymyxins combinations.
    Polyudova T; Lemkina L; Eroshenko D; Esaev A
    Arch Microbiol; 2024 Mar; 206(4):191. PubMed ID: 38520490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of polymyxin B on ion permeability of bacterial membranes].
    Kapitanova NG; Korepanova EA; Gariaev AA; Frolov VN; Antonov VF
    Biofizika; 1981; 26(6):1100-2. PubMed ID: 6274432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli.
    Dixon RA; Chopra I
    J Antimicrob Chemother; 1986 Nov; 18(5):557-63. PubMed ID: 3027012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
    Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
    J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism of the antimicrobial agents miconazole, bacitracin and polymyxin B.
    Cornelissen F; Van den Bossche H
    Chemotherapy; 1983; 29(6):419-27. PubMed ID: 6317296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of specific growth rate and nutrient-limitation upon the sensitivity of Escherichia coli towards polymyxin B.
    Wright NE; Gilbert P
    J Antimicrob Chemother; 1987 Sep; 20(3):303-12. PubMed ID: 2824423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature dependence of bactericidal action of polymyxin B.
    Hodate K; Bito Y
    Microbiol Immunol; 1982; 26(8):737-40. PubMed ID: 6294487
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative proteomic analysis reveals the mechanisms of polymyxin B toxicity to Escherichia coli.
    Liu J; Huang Z; Ruan B; Wang H; Chen M; Rehman S; Wu P
    Chemosphere; 2020 Nov; 259():127449. PubMed ID: 32622246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
    Vaara M; Viljanen P; Vaara T; Mäkelä PH
    J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of polymyxin B nonapeptide (PMBN) on transformation.
    Viljanen P
    Biochem Biophys Res Commun; 1987 Mar; 143(3):923-7. PubMed ID: 3032189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding to and antibacterial effect of ampicillin, neomycin and polymyxin B on human faeces.
    Hazenberg MP; Pennock-Schröder AM; Van den Boom M; Van de Merwe JP
    J Hyg (Lond); 1984 Aug; 93(1):27-34. PubMed ID: 6086749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estimating the biological effect of detrimental substances on E. coli with flow microcalorimetry. II. Studies using 3 antibiotics].
    Hartung J
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1986 Dec; 183(1):47-57. PubMed ID: 3033951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytotoxicity and antibiotic activity of polymyxin B nonapeptide.
    Duwe AK; Rupar CA; Horsman GB; Vas SI
    Antimicrob Agents Chemother; 1986 Aug; 30(2):340-1. PubMed ID: 3021053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B.
    Traub WH
    Chemotherapy; 1982; 28(5):363-8. PubMed ID: 6291867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide.
    Dixon RA; Chopra I
    Antimicrob Agents Chemother; 1986 May; 29(5):781-8. PubMed ID: 3015004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical and preparative high-performance liquid chromatography of the papain-cleaved derivative of polymyxin B.
    Vaara M
    J Chromatogr; 1988 Jun; 441(2):423-30. PubMed ID: 2842355
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid and lipopolysaccharide composition of Escherichia coli surface-altered mutants selected for resistance to levallorphan, tetracaine, and polymyxin.
    Dame JB; Shapiro BM
    J Bacteriol; 1979 Feb; 137(2):1043-7. PubMed ID: 217864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.